4/A

PRIMARY DOCUMENT

Company: GALECTIN THERAPEUTICS INC
Filed: June 3, 2019
Period of Report: May 29, 2019
Accession Number: 0001179022-19-000038

View Document ↗ View on SEC.gov ↗